XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Equity (Deficit) - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Noncontrolling Interest [Member]
Retained Earnings [Member]
Balance at Dec. 31, 2022 $ 36,340,523 $ 2,721 $ 127,869,342 $ 448,694 $ (91,980,234)
Balance, shares at Dec. 31, 2022   2,720,171      
Stock-based compensation 452,071 452,071
Restricted common stock  grant $ 35 (35)
Restricted common stock grant, shares   35,000      
Restricted common stock forfeitures $ (4) 4
Restricted common stock forfeitures, shares (3,625) (3,625)      
Conversion of convertible note into common stock $ 119,750 $ 25 119,725
Conversion of convertible note into common stock, shares   25,000      
Issuance due to rounding from reverse stock split $ 24 (24)
Issuance due to rounding from reverse stock split, shares   24,208      
Net loss (25,463,949) 224,598 (25,688,547)
Balance at Dec. 31, 2023 11,448,395 $ 2,801 128,441,083 673,292 (117,668,781)
Balance, shares at Dec. 31, 2023   2,800,754      
Stock-based compensation 128,519 128,519
Restricted common stock  grant $ 80 (80)
Restricted common stock grant, shares   80,197      
Restricted common stock forfeitures $ (49) 49
Restricted common stock forfeitures, shares (49,947) (49,947)      
Net loss $ (21,715,725) (1,871,578) (19,844,147)
Sale of common stock and pre-funded warrants, net of offering costs 2,529,448 $ 622 2,528,826
Sale of common stock and pre-funded warrants, net of offering costs, shares   622,211      
Fair value of warrants issued along with sale of common stock (2,075,300) (2,075,300)
Issuance of commitment shares in connection with bridge financing 539,455 $ 808 538,647
Issuance of commitment shares in connection with bridge financing, shares   808,377      
Issuance of common stock upon exercise of pre-funded warrants $ 573 (573)
Issuance of common stock upon exercise of prefunded warrants, shares   573,004      
Allocation of fair value of Series B warrants approved by shareholders (454,150) (454,150)
Transition of warrant derivative liability to equity upon exercise of Series B warrants 584,955 584,955
Issuance of common stock upon exercise of common stock purchase warrants 973 $ 973
Issuance of common stock upon exercise of common stock purchase warrants, shares   973,000      
Balance at Dec. 31, 2024 $ (9,013,430) $ 5,808 $ 129,691,976 $ (1,198,286) $ (137,512,928)
Balance, shares at Dec. 31, 2024   5,807,596